• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GAB1 基因与儿童哮喘易感性及吸入性皮质类固醇疗效的相关性研究。

Association of GAB1 gene with asthma susceptibility and the efficacy of inhaled corticosteroids in children.

机构信息

Department of neonatology, General Hospital of Northern Theater Command, Shenyang, 110016, Liaoning, People's Republic of China.

Post-graduate College, Jinzhou Medical University, Jinzhou, 121000, Liaoning, People's Republic of China.

出版信息

BMC Pulm Med. 2023 Dec 6;23(1):493. doi: 10.1186/s12890-023-02790-0.

DOI:10.1186/s12890-023-02790-0
PMID:38057792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10698945/
Abstract

Asthma is a polygenic disease that may onset during childhood. Inhaled corticosteroids (ICS) are the main therapy in asthma, although their efficacy varies among individuals. Nuclear factor κB (NF-κB) is an important target of ICS treatment of asthma. Recent research has reported that GRB2 associated binding protein 1 (GAB1) gene may participate in the pathogenesis of asthma by regulating the NF-κB pathway. Therefore, we used the technique of an improved multiplex ligation detection reaction to sequence GAB1 gene and investigated the involvement of Single-nucleotide variants (SNVs) in GAB1 gene in asthma and ICS efficacy in asthmatic children. We found no differences between asthma cases and controls in allele or genotype frequencies of GAB1. Haplotype analysis showed an increased tendency for AGGAGC frequency in asthma patients compared with controls (OR = 2.69, p = 0.018). The percentage of EOS and genotype distribution of rs1397527 were associated (p = 0.007). The EOS percentage was higher in GT genotype when compared to the GG genotype (5.50 vs 3.00, Bonferroni adjusted p = 0.005). After 12-weeks ICS treatment, GAB1 rs1397527 TT and GT genotype carriers had a smaller change in forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) than GG carriers (p = 0.009), and rs3805236 GG and AG genotype carriers also had a smaller change in FEV1/FVC than AA carriers (p = 0.025). For ICS response, the frequency of GG genotype of rs1397527 was significantly higher in good responders (p = 0.038). The generalized multifactor dimensionality reduction (GMDR) analysis showed a best significant four-order model (rs1397527, allergen exposure, environmental tobacco smoke exposure, and pet exposure) involving gene-environment interactions (p = 0.001). In summary, we found that GAB1 SNVs were not associated with asthma susceptibility. Haplotype AGGAGC was a risk factor for asthma. GAB1 variants were associated with eosinophils and ICS response in asthmatics. Furthermore, gene-environment interaction was observed.

摘要

哮喘是一种多基因疾病,可能在儿童时期发病。吸入性皮质类固醇(ICS)是哮喘的主要治疗方法,尽管其疗效在个体之间有所不同。核因子 kappa B(NF-κB)是 ICS 治疗哮喘的重要靶点。最近的研究表明,GRB2 相关结合蛋白 1(GAB1)基因可能通过调节 NF-κB 途径参与哮喘的发病机制。因此,我们使用改良多重连接检测反应技术对 GAB1 基因进行测序,并研究 GAB1 基因中的单核苷酸变异(SNVs)在哮喘和哮喘儿童 ICS 疗效中的作用。我们发现哮喘病例和对照组之间 GAB1 等位基因或基因型频率无差异。单体型分析显示哮喘患者中 AGGAGC 频率呈增加趋势,与对照组相比(OR=2.69,p=0.018)。EOS 百分比和 rs1397527 基因型分布相关(p=0.007)。与 GG 基因型相比,GT 基因型的 EOS 百分比更高(5.50 比 3.00,Bonferroni 校正 p=0.005)。ICS 治疗 12 周后,GAB1 rs1397527 TT 和 GT 基因型携带者的用力呼气量 1 秒/用力肺活量(FEV1/FVC)变化小于 GG 携带者(p=0.009),rs3805236 GG 和 AG 基因型携带者的 FEV1/FVC 变化也小于 AA 携带者(p=0.025)。对于 ICS 反应,rs1397527 GG 基因型的良好反应者频率明显较高(p=0.038)。广义多因素维度缩减(GMDR)分析显示,基因-环境相互作用的最佳显著四阶模型(rs1397527、过敏原暴露、环境烟草烟雾暴露和宠物暴露)(p=0.001)。综上所述,我们发现 GAB1 SNVs 与哮喘易感性无关。单体型 AGGAGC 是哮喘的危险因素。GAB1 变体与哮喘患者的嗜酸性粒细胞和 ICS 反应有关。此外,还观察到基因-环境相互作用。

相似文献

1
Association of GAB1 gene with asthma susceptibility and the efficacy of inhaled corticosteroids in children.GAB1 基因与儿童哮喘易感性及吸入性皮质类固醇疗效的相关性研究。
BMC Pulm Med. 2023 Dec 6;23(1):493. doi: 10.1186/s12890-023-02790-0.
2
The GLCCI1 rs37973 variant and the efficacy of inhaled corticosteroids in the treatment of asthma: A meta-analysis.GLCCI1 rs37973 变异体与吸入性皮质类固醇治疗哮喘的疗效:一项荟萃分析。
Clin Respir J. 2023 Jun;17(6):568-579. doi: 10.1111/crj.13627. Epub 2023 May 8.
3
Gene polymorphisms in and are associated with response to inhaled corticosteroids in children with asthma.和 基因多态性与哮喘儿童吸入皮质激素反应相关。
Pharmacogenomics. 2019 Aug;20(13):947-955. doi: 10.2217/pgs-2019-0036.
4
GLCCI1 and STIP1 variants are associated with asthma susceptibility and inhaled corticosteroid response in a Tunisian population.GLCCI1 和 STIP1 变体与突尼斯人群的哮喘易感性和吸入皮质类固醇反应相关。
J Asthma. 2021 Feb;58(2):197-206. doi: 10.1080/02770903.2019.1666867. Epub 2019 Sep 24.
5
Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.吸入长效β2受体激动剂与吸入性糖皮质激素联合使用与高剂量吸入性糖皮质激素治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2005 Oct 19(4):CD005533. doi: 10.1002/14651858.CD005533.
6
Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects.通过自我报告的种族和基因血统评估哮喘患者吸入性糖皮质激素反应的差异。
J Allergy Clin Immunol. 2016 May;137(5):1364-1369.e2. doi: 10.1016/j.jaci.2015.12.1334. Epub 2016 Mar 22.
7
Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.间歇性与每日吸入皮质类固醇治疗儿童和成人持续性哮喘的比较
Cochrane Database Syst Rev. 2013 Feb 28;2013(2):CD009611. doi: 10.1002/14651858.CD009611.pub3.
8
Functional polymorphism in CTLA4 gene influences the response to therapy with inhaled corticosteroids in Slovenian children with atopic asthma.CTLA4 基因功能多态性影响吸入性皮质类固醇治疗斯洛文尼亚特应性哮喘儿童的反应。
Biomarkers. 2010 Mar;15(2):158-66. doi: 10.3109/13547500903384318.
9
G894T polymorphism of eNOS gene is a predictor of response to combination of inhaled corticosteroids with long-lasting β2-agonists in asthmatic children.eNOS 基因 G894T 多态性是预测哮喘儿童吸入糖皮质激素联合长效β2-受体激动剂疗效的指标。
Pharmacogenomics. 2012 Sep;13(12):1363-72. doi: 10.2217/pgs.12.120.
10
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.吸入性皮质类固醇与色甘酸钠用于儿童和成人哮喘患者的比较
Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD003558. doi: 10.1002/14651858.CD003558.pub2.

本文引用的文献

1
The Global Asthma Report 2022.《2022年全球哮喘报告》
Int J Tuberc Lung Dis. 2022 Nov 25;26(Supp 1):1-104. doi: 10.5588/ijtld.22.1010.
2
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.成人和儿童慢性哮喘加重时,增加与稳定剂量的吸入皮质类固醇。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD007524. doi: 10.1002/14651858.CD007524.pub5.
3
Environmental inequality: Air pollution and asthma in children.环境不平等:空气污染与儿童哮喘。
Pediatr Allergy Immunol. 2022 Jun;33(6). doi: 10.1111/pai.13818.
4
Gene-environment interactions in childhood asthma revisited; expanding the interaction concept.重新探讨儿童哮喘中的基因-环境相互作用;扩展相互作用概念。
Pediatr Allergy Immunol. 2022 May;33(5):e13780. doi: 10.1111/pai.13780.
5
The influence of urban exposures and residence on childhood asthma.城市暴露因素及居住环境对儿童哮喘的影响。
Pediatr Allergy Immunol. 2022 May;33(5):e13784. doi: 10.1111/pai.13784.
6
Association of Single-Nucleotide Polymorphisms of Gab1 Gene with Susceptibility to Meningioma in a Northern Chinese Han Population.Gab1 基因单核苷酸多态性与中国北方汉族人群脑膜瘤易感性的关联。
Med Sci Monit. 2021 Nov 4;27:e933444. doi: 10.12659/MSM.933444.
7
Asthma genomics and pharmacogenomics.哮喘基因组学与药物基因组学。
Curr Opin Immunol. 2020 Oct;66:136-142. doi: 10.1016/j.coi.2020.10.001. Epub 2020 Nov 7.
8
The genetics of asthma and the promise of genomics-guided drug target discovery.哮喘的遗传学与基于基因组学的药物靶点发现的前景。
Lancet Respir Med. 2020 Oct;8(10):1045-1056. doi: 10.1016/S2213-2600(20)30363-5. Epub 2020 Sep 7.
9
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy.吸入性糖皮质激素治疗哮喘的药物基因组学反应:治疗考量
Pharmgenomics Pers Med. 2020 Aug 4;13:261-271. doi: 10.2147/PGPM.S231471. eCollection 2020.
10
Targeting cell signaling in allergic asthma.靶向变应性哮喘中的细胞信号转导。
Signal Transduct Target Ther. 2019 Oct 18;4:45. doi: 10.1038/s41392-019-0079-0. eCollection 2019.